| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | calcium ion binding | 1.02e-05 | 749 | 15 | 6 | GO:0005509 | |
| GeneOntologyBiologicalProcess | regulation of nervous system development | 5.87e-05 | 625 | 15 | 5 | GO:0051960 | |
| GeneOntologyBiologicalProcess | positive regulation by symbiont of entry into host | 5.89e-05 | 16 | 15 | 2 | GO:0075294 | |
| GeneOntologyBiologicalProcess | positive regulation of viral entry into host cell | 5.89e-05 | 16 | 15 | 2 | GO:0046598 | |
| GeneOntologyBiologicalProcess | viral translation | 9.31e-05 | 20 | 15 | 2 | GO:0019081 | |
| GeneOntologyBiologicalProcess | embryonic limb morphogenesis | 1.55e-04 | 148 | 15 | 3 | GO:0030326 | |
| GeneOntologyBiologicalProcess | embryonic appendage morphogenesis | 1.55e-04 | 148 | 15 | 3 | GO:0035113 | |
| GeneOntologyBiologicalProcess | positive regulation of viral life cycle | 1.71e-04 | 27 | 15 | 2 | GO:1903902 | |
| GeneOntologyBiologicalProcess | appendage morphogenesis | 2.98e-04 | 185 | 15 | 3 | GO:0035107 | |
| GeneOntologyBiologicalProcess | limb morphogenesis | 2.98e-04 | 185 | 15 | 3 | GO:0035108 | |
| GeneOntologyBiologicalProcess | embryo development | 3.27e-04 | 1437 | 15 | 6 | GO:0009790 | |
| GeneOntologyBiologicalProcess | regulation of neurogenesis | 4.21e-04 | 515 | 15 | 4 | GO:0050767 | |
| GeneOntologyBiologicalProcess | limb development | 5.22e-04 | 224 | 15 | 3 | GO:0060173 | |
| GeneOntologyBiologicalProcess | appendage development | 5.22e-04 | 224 | 15 | 3 | GO:0048736 | |
| GeneOntologyBiologicalProcess | regulation of viral entry into host cell | 7.17e-04 | 55 | 15 | 2 | GO:0046596 | |
| GeneOntologyBiologicalProcess | modulation by symbiont of entry into host | 9.10e-04 | 62 | 15 | 2 | GO:0052372 | |
| GeneOntologyBiologicalProcess | zymogen activation | 1.00e-03 | 65 | 15 | 2 | GO:0031638 | |
| GeneOntologyBiologicalProcess | regulation of platelet activation | 1.03e-03 | 66 | 15 | 2 | GO:0010543 | |
| GeneOntologyBiologicalProcess | protein processing | 1.05e-03 | 285 | 15 | 3 | GO:0016485 | |
| GeneOntologyBiologicalProcess | positive regulation of viral process | 1.13e-03 | 69 | 15 | 2 | GO:0048524 | |
| GeneOntologyBiologicalProcess | enzyme-linked receptor protein signaling pathway | 1.15e-03 | 1186 | 15 | 5 | GO:0007167 | |
| GeneOntologyBiologicalProcess | morphogenesis of an epithelial sheet | 1.29e-03 | 74 | 15 | 2 | GO:0002011 | |
| GeneOntologyBiologicalProcess | embryonic digit morphogenesis | 1.29e-03 | 74 | 15 | 2 | GO:0042733 | |
| GeneOntologyBiologicalProcess | regulation of biological process involved in symbiotic interaction | 1.33e-03 | 75 | 15 | 2 | GO:0043903 | |
| GeneOntologyBiologicalProcess | determination of heart left/right asymmetry | 1.47e-03 | 79 | 15 | 2 | GO:0061371 | |
| GeneOntologyBiologicalProcess | embryonic heart tube morphogenesis | 1.51e-03 | 80 | 15 | 2 | GO:0003143 | |
| GeneOntologyBiologicalProcess | positive regulation of small GTPase mediated signal transduction | 1.99e-03 | 92 | 15 | 2 | GO:0051057 | |
| GeneOntologyBiologicalProcess | kidney development | 2.25e-03 | 372 | 15 | 3 | GO:0001822 | |
| GeneOntologyBiologicalProcess | inflammatory response to antigenic stimulus | 2.49e-03 | 103 | 15 | 2 | GO:0002437 | |
| GeneOntologyBiologicalProcess | embryonic heart tube development | 2.49e-03 | 103 | 15 | 2 | GO:0035050 | |
| GeneOntologyBiologicalProcess | renal system development | 2.50e-03 | 386 | 15 | 3 | GO:0072001 | |
| MousePheno | abnormal femur compact bone thickness | 8.48e-07 | 23 | 12 | 3 | MP:0013622 | |
| MousePheno | abnormal limb morphology | 6.50e-06 | 1028 | 12 | 7 | MP:0002109 | |
| MousePheno | increased femur compact bone thickness | 1.42e-05 | 7 | 12 | 2 | MP:0013623 | |
| MousePheno | abnormal femur morphology | 2.40e-05 | 214 | 12 | 4 | MP:0000559 | |
| MousePheno | abnormal hindlimb stylopod morphology | 2.45e-05 | 215 | 12 | 4 | MP:0003856 | |
| MousePheno | limbs/digits/tail phenotype | 2.48e-05 | 1258 | 12 | 7 | MP:0005371 | |
| MousePheno | abnormal appendicular skeleton morphology | 4.51e-05 | 896 | 12 | 6 | MP:0009250 | |
| MousePheno | increased growth rate | 7.05e-05 | 15 | 12 | 2 | MP:0002865 | |
| MousePheno | abnormal compact bone thickness | 1.35e-04 | 122 | 12 | 3 | MP:0000134 | |
| MousePheno | abnormal myocardial trabeculae morphology | 2.20e-04 | 144 | 12 | 3 | MP:0002189 | |
| MousePheno | abnormal trabecular bone connectivity density | 2.34e-04 | 27 | 12 | 2 | MP:0010931 | |
| MousePheno | increased bone ossification | 3.30e-04 | 32 | 12 | 2 | MP:0020039 | |
| MousePheno | abnormal heart layer morphology | 3.34e-04 | 422 | 12 | 4 | MP:0010545 | |
| MousePheno | brachydactyly | 3.51e-04 | 33 | 12 | 2 | MP:0002544 | |
| MousePheno | abnormal compact bone morphology | 3.71e-04 | 172 | 12 | 3 | MP:0003797 | |
| MousePheno | abnormal vibrissa morphology | 4.59e-04 | 185 | 12 | 3 | MP:0002098 | |
| MousePheno | impaired branching involved in ureteric bud morphogenesis | 5.44e-04 | 41 | 12 | 2 | MP:0004936 | |
| MousePheno | increased compact bone thickness | 5.44e-04 | 41 | 12 | 2 | MP:0004148 | |
| MousePheno | renal hypoplasia | 6.26e-04 | 44 | 12 | 2 | MP:0003446 | |
| MousePheno | abnormal branching involved in ureteric bud morphogenesis | 6.55e-04 | 45 | 12 | 2 | MP:0010981 | |
| MousePheno | abnormal bone trabecular spacing | 7.45e-04 | 48 | 12 | 2 | MP:0013629 | |
| MousePheno | skin edema | 9.09e-04 | 53 | 12 | 2 | MP:0001786 | |
| MousePheno | abnormal limb long bone morphology | 1.03e-03 | 568 | 12 | 4 | MP:0011504 | |
| MousePheno | abnormal ureteric bud morphology | 1.05e-03 | 57 | 12 | 2 | MP:0006032 | |
| MousePheno | abnormal hindlimb morphology | 1.08e-03 | 576 | 12 | 4 | MP:0000556 | |
| MousePheno | abnormal limb bone morphology | 1.16e-03 | 587 | 12 | 4 | MP:0002115 | |
| MousePheno | abnormal skeleton physiology | 1.53e-03 | 632 | 12 | 4 | MP:0001533 | |
| MousePheno | prolonged QRS complex duration | 1.72e-03 | 73 | 12 | 2 | MP:0010392 | |
| MousePheno | intraventricular block | 1.76e-03 | 74 | 12 | 2 | MP:0010560 | |
| MousePheno | bundle branch block | 1.76e-03 | 74 | 12 | 2 | MP:0010636 | |
| Domain | Growth_fac_rcpt_ | 1.51e-11 | 156 | 15 | 7 | IPR009030 | |
| Domain | EGF_CA | 3.86e-11 | 86 | 15 | 6 | PF07645 | |
| Domain | EGF_Ca-bd_CS | 8.09e-11 | 97 | 15 | 6 | IPR018097 | |
| Domain | EGF_CA | 9.16e-11 | 99 | 15 | 6 | PS01187 | |
| Domain | ASX_HYDROXYL | 9.74e-11 | 100 | 15 | 6 | PS00010 | |
| Domain | EGF-type_Asp/Asn_hydroxyl_site | 1.39e-10 | 106 | 15 | 6 | IPR000152 | |
| Domain | EGF_3 | 2.70e-10 | 235 | 15 | 7 | PS50026 | |
| Domain | EGF_CA | 3.27e-10 | 122 | 15 | 6 | SM00179 | |
| Domain | EGF-like_Ca-bd_dom | 3.61e-10 | 124 | 15 | 6 | IPR001881 | |
| Domain | EGF_1 | 4.78e-10 | 255 | 15 | 7 | PS00022 | |
| Domain | EGF_2 | 6.25e-10 | 265 | 15 | 7 | PS01186 | |
| Domain | EGF | 1.69e-08 | 235 | 15 | 6 | SM00181 | |
| Domain | EGF-like_dom | 2.39e-08 | 249 | 15 | 6 | IPR000742 | |
| Domain | LDLR_class-A_CS | 2.42e-08 | 40 | 15 | 4 | IPR023415 | |
| Domain | EGF-like_CS | 3.17e-08 | 261 | 15 | 6 | IPR013032 | |
| Domain | EGF | 3.67e-08 | 126 | 15 | 5 | PF00008 | |
| Domain | - | 4.31e-08 | 46 | 15 | 4 | 4.10.400.10 | |
| Domain | LDLRA_1 | 5.13e-08 | 48 | 15 | 4 | PS01209 | |
| Domain | LDrepeatLR_classA_rpt | 5.59e-08 | 49 | 15 | 4 | IPR002172 | |
| Domain | LDLa | 5.59e-08 | 49 | 15 | 4 | SM00192 | |
| Domain | LDLRA_2 | 5.59e-08 | 49 | 15 | 4 | PS50068 | |
| Domain | cEGF | 1.08e-06 | 26 | 15 | 3 | IPR026823 | |
| Domain | cEGF | 1.08e-06 | 26 | 15 | 3 | PF12662 | |
| Domain | Ldl_recept_a | 5.83e-06 | 45 | 15 | 3 | PF00057 | |
| Domain | Ephrin_rec_like | 3.30e-05 | 11 | 15 | 2 | PF07699 | |
| Domain | Ldl_recept_b | 5.45e-05 | 14 | 15 | 2 | PF00058 | |
| Domain | LDLRB | 5.45e-05 | 14 | 15 | 2 | PS51120 | |
| Domain | LY | 6.28e-05 | 15 | 15 | 2 | SM00135 | |
| Domain | LDLR_classB_rpt | 6.28e-05 | 15 | 15 | 2 | IPR000033 | |
| Domain | Ephrin_rec_like | 1.79e-04 | 25 | 15 | 2 | SM01411 | |
| Domain | Tyr-kin_ephrin_A/B_rcpt-like | 1.79e-04 | 25 | 15 | 2 | IPR011641 | |
| Domain | hEGF | 2.25e-04 | 28 | 15 | 2 | PF12661 | |
| Domain | - | 4.39e-04 | 39 | 15 | 2 | 2.120.10.30 | |
| Domain | 6-blade_b-propeller_TolB-like | 6.11e-04 | 46 | 15 | 2 | IPR011042 | |
| Domain | EGF_extracell | 1.04e-03 | 60 | 15 | 2 | IPR013111 | |
| Domain | EGF_2 | 1.04e-03 | 60 | 15 | 2 | PF07974 | |
| Domain | - | 1.53e-03 | 73 | 15 | 2 | 2.60.120.260 | |
| Domain | Galactose-bd-like | 2.52e-03 | 94 | 15 | 2 | IPR008979 | |
| Pathway | PID_NOTCH_PATHWAY | 1.12e-05 | 59 | 11 | 3 | M17 | |
| Pathway | WP_SARSCOV2_AND_COVID19_PATHWAY | 2.48e-05 | 10 | 11 | 2 | M40050 | |
| Pathway | REACTOME_INDUCTION_OF_CELL_CELL_FUSION | 4.30e-05 | 13 | 11 | 2 | M46426 | |
| Pathway | REACTOME_PRE_NOTCH_PROCESSING_IN_GOLGI | 8.41e-05 | 18 | 11 | 2 | M614 | |
| Pathway | REACTOME_ATTACHMENT_AND_ENTRY | 9.40e-05 | 19 | 11 | 2 | M41729 | |
| Pathway | WP_POSTCOVID_NEUROINFLAMMATION | 1.39e-04 | 23 | 11 | 2 | M48313 | |
| Pathway | REACTOME_EARLY_SARS_COV_2_INFECTION_EVENTS | 3.63e-04 | 37 | 11 | 2 | M45028 | |
| Pathway | REACTOME_DISEASES_ASSOCIATED_WITH_O_GLYCOSYLATION_OF_PROTEINS | 1.23e-03 | 68 | 11 | 2 | M27303 | |
| Pathway | REACTOME_LATE_SARS_COV_2_INFECTION_EVENTS | 1.30e-03 | 70 | 11 | 2 | M46438 | |
| Pathway | WP_DELTANOTCH_SIGNALING_PATHWAY | 1.78e-03 | 82 | 11 | 2 | MM15922 | |
| Pubmed | 1.74e-07 | 2 | 15 | 2 | 9325052 | ||
| Pubmed | Regulation of Stress Responses and Translational Control by Coronavirus. | 1.74e-07 | 2 | 15 | 2 | 27384577 | |
| Pubmed | TMPRSS2 and furin are both essential for proteolytic activation of SARS-CoV-2 in human airway cells. | 1.74e-07 | 2 | 15 | 2 | 32703818 | |
| Pubmed | Distinctive Roles of Furin and TMPRSS2 in SARS-CoV-2 Infectivity. | 1.74e-07 | 2 | 15 | 2 | 35343766 | |
| Pubmed | 5.21e-07 | 3 | 15 | 2 | 34356057 | ||
| Pubmed | ACE2, TMPRSS2, and Furin variants and SARS-CoV-2 infection in Madrid, Spain. | 5.21e-07 | 3 | 15 | 2 | 32691890 | |
| Pubmed | 5.21e-07 | 3 | 15 | 2 | 33243086 | ||
| Pubmed | 5.21e-07 | 3 | 15 | 2 | 22930729 | ||
| Pubmed | Tobacco Smoking Increases the Lung Gene Expression of ACE2, the Receptor of SARS-CoV-2. | 5.21e-07 | 3 | 15 | 2 | 32329629 | |
| Pubmed | 5.21e-07 | 3 | 15 | 2 | 34726347 | ||
| Pubmed | Evaluation of various endothelial biomarkers in ankylosing spondylitis. | 5.21e-07 | 3 | 15 | 2 | 21556780 | |
| Pubmed | TMPRSS2 promotes SARS-CoV-2 evasion from NCOA7-mediated restriction. | 5.21e-07 | 3 | 15 | 2 | 34807954 | |
| Pubmed | COVID-19 and Genetic Variants of Protein Involved in the SARS-CoV-2 Entry into the Host Cells. | 1.04e-06 | 4 | 15 | 2 | 32867305 | |
| Pubmed | 1.04e-06 | 4 | 15 | 2 | 28923203 | ||
| Pubmed | 1.04e-06 | 4 | 15 | 2 | 35038715 | ||
| Pubmed | 1.73e-06 | 5 | 15 | 2 | 20383322 | ||
| Pubmed | EZH2-induced lysine K362 methylation enhances TMPRSS2-ERG oncogenic activity in prostate cancer. | 1.73e-06 | 5 | 15 | 2 | 34230470 | |
| Pubmed | Multiomics approach reveals the ubiquitination-specific processes hijacked by SARS-CoV-2. | 2.60e-06 | 6 | 15 | 2 | 36071039 | |
| Pubmed | N-Myc Induces an EZH2-Mediated Transcriptional Program Driving Neuroendocrine Prostate Cancer. | 3.64e-06 | 7 | 15 | 2 | 27728805 | |
| Pubmed | 6.24e-06 | 9 | 15 | 2 | 9693030 | ||
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | 6.41e-06 | 1201 | 15 | 6 | 35696571 | |
| Pubmed | 9.53e-06 | 11 | 15 | 2 | 24639464 | ||
| Pubmed | 1.58e-05 | 14 | 15 | 2 | 15082773 | ||
| Pubmed | MESD is essential for apical localization of megalin/LRP2 in the visceral endoderm. | 3.63e-05 | 21 | 15 | 2 | 21337463 | |
| Interaction | ADAMTS1 interactions | 4.47e-07 | 95 | 14 | 4 | int:ADAMTS1 | |
| Interaction | NTN5 interactions | 5.36e-07 | 24 | 14 | 3 | int:NTN5 | |
| Interaction | ZSCAN21 interactions | 1.48e-06 | 128 | 14 | 4 | int:ZSCAN21 | |
| Interaction | HSP90B1 interactions | 2.65e-06 | 650 | 14 | 6 | int:HSP90B1 | |
| Interaction | ZFP41 interactions | 7.64e-06 | 57 | 14 | 3 | int:ZFP41 | |
| Interaction | CRISPLD1 interactions | 9.39e-06 | 7 | 14 | 2 | int:CRISPLD1 | |
| Interaction | IGFL3 interactions | 1.75e-05 | 75 | 14 | 3 | int:IGFL3 | |
| Interaction | ZNF563 interactions | 2.95e-05 | 12 | 14 | 2 | int:ZNF563 | |
| Interaction | ZNF146 interactions | 3.13e-05 | 91 | 14 | 3 | int:ZNF146 | |
| Interaction | PFKP interactions | 3.46e-05 | 284 | 14 | 4 | int:PFKP | |
| Interaction | RNASE4 interactions | 4.06e-05 | 14 | 14 | 2 | int:RNASE4 | |
| Interaction | IGSF5 interactions | 4.06e-05 | 14 | 14 | 2 | int:IGSF5 | |
| Interaction | TG interactions | 4.06e-05 | 14 | 14 | 2 | int:TG | |
| Interaction | DEFB123 interactions | 5.35e-05 | 16 | 14 | 2 | int:DEFB123 | |
| Interaction | LANCL1 interactions | 5.82e-05 | 112 | 14 | 3 | int:LANCL1 | |
| Interaction | SULF2 interactions | 6.97e-05 | 119 | 14 | 3 | int:SULF2 | |
| Interaction | RPL10 interactions | 7.79e-05 | 702 | 14 | 5 | int:RPL10 | |
| Interaction | ZNF224 interactions | 8.45e-05 | 20 | 14 | 2 | int:ZNF224 | |
| Interaction | ATP2A2 interactions | 9.57e-05 | 369 | 14 | 4 | int:ATP2A2 | |
| Interaction | PGRMC1 interactions | 1.02e-04 | 375 | 14 | 4 | int:PGRMC1 | |
| Interaction | DDOST interactions | 1.02e-04 | 375 | 14 | 4 | int:DDOST | |
| Interaction | RAB6A interactions | 1.15e-04 | 141 | 14 | 3 | int:RAB6A | |
| Interaction | ZNF408 interactions | 1.25e-04 | 145 | 14 | 3 | int:ZNF408 | |
| Interaction | STAM2 interactions | 1.30e-04 | 147 | 14 | 3 | int:STAM2 | |
| Interaction | RPN1 interactions | 1.57e-04 | 814 | 14 | 5 | int:RPN1 | |
| Interaction | FEZF1 interactions | 1.68e-04 | 28 | 14 | 2 | int:FEZF1 | |
| Interaction | VDAC2 interactions | 1.76e-04 | 432 | 14 | 4 | int:VDAC2 | |
| Interaction | CTSD interactions | 1.90e-04 | 167 | 14 | 3 | int:CTSD | |
| Interaction | ZNF107 interactions | 2.06e-04 | 31 | 14 | 2 | int:ZNF107 | |
| Interaction | IMMT interactions | 2.13e-04 | 454 | 14 | 4 | int:IMMT | |
| Interaction | RAB7A interactions | 2.33e-04 | 886 | 14 | 5 | int:RAB7A | |
| Interaction | ARPC3 interactions | 2.49e-04 | 183 | 14 | 3 | int:ARPC3 | |
| Interaction | RAB10 interactions | 2.78e-04 | 190 | 14 | 3 | int:RAB10 | |
| Interaction | ZNF724 interactions | 2.79e-04 | 36 | 14 | 2 | int:ZNF724 | |
| Interaction | PABPN1 interactions | 2.87e-04 | 192 | 14 | 3 | int:PABPN1 | |
| Interaction | BRICD5 interactions | 2.96e-04 | 194 | 14 | 3 | int:BRICD5 | |
| Interaction | IGFBP4 interactions | 3.62e-04 | 41 | 14 | 2 | int:IGFBP4 | |
| Interaction | SERPINA5 interactions | 3.62e-04 | 41 | 14 | 2 | int:SERPINA5 | |
| Interaction | DEK interactions | 3.68e-04 | 209 | 14 | 3 | int:DEK | |
| Interaction | PFKL interactions | 3.94e-04 | 214 | 14 | 3 | int:PFKL | |
| Interaction | ZNF398 interactions | 3.98e-04 | 43 | 14 | 2 | int:ZNF398 | |
| Interaction | HSD17B12 interactions | 4.27e-04 | 220 | 14 | 3 | int:HSD17B12 | |
| Interaction | SEC61A1 interactions | 4.45e-04 | 223 | 14 | 3 | int:SEC61A1 | |
| Interaction | DYRK1A interactions | 4.48e-04 | 552 | 14 | 4 | int:DYRK1A | |
| Interaction | ZNF121 interactions | 4.56e-04 | 46 | 14 | 2 | int:ZNF121 | |
| Interaction | AIF1L interactions | 4.96e-04 | 48 | 14 | 2 | int:AIF1L | |
| Interaction | FOXD4L6 interactions | 5.17e-04 | 49 | 14 | 2 | int:FOXD4L6 | |
| Interaction | SEC31A interactions | 5.25e-04 | 236 | 14 | 3 | int:SEC31A | |
| Interaction | LCOR interactions | 5.64e-04 | 242 | 14 | 3 | int:LCOR | |
| Interaction | TMOD3 interactions | 5.71e-04 | 243 | 14 | 3 | int:TMOD3 | |
| Interaction | YTHDF3 interactions | 5.92e-04 | 246 | 14 | 3 | int:YTHDF3 | |
| Interaction | RRM2B interactions | 6.05e-04 | 53 | 14 | 2 | int:RRM2B | |
| Interaction | ZNF518A interactions | 6.28e-04 | 54 | 14 | 2 | int:ZNF518A | |
| Interaction | RAB1B interactions | 6.42e-04 | 253 | 14 | 3 | int:RAB1B | |
| Interaction | PRKCSH interactions | 6.72e-04 | 257 | 14 | 3 | int:PRKCSH | |
| Interaction | MEGF8 interactions | 6.75e-04 | 56 | 14 | 2 | int:MEGF8 | |
| Interaction | TPM4 interactions | 6.88e-04 | 259 | 14 | 3 | int:TPM4 | |
| Interaction | SLC25A13 interactions | 7.19e-04 | 263 | 14 | 3 | int:SLC25A13 | |
| Interaction | LYPD1 interactions | 7.24e-04 | 58 | 14 | 2 | int:LYPD1 | |
| Interaction | ZSCAN26 interactions | 7.50e-04 | 59 | 14 | 2 | int:ZSCAN26 | |
| Interaction | ANKRD36B interactions | 7.75e-04 | 60 | 14 | 2 | int:ANKRD36B | |
| Interaction | MYO1B interactions | 8.01e-04 | 273 | 14 | 3 | int:MYO1B | |
| Interaction | CNBP interactions | 8.27e-04 | 276 | 14 | 3 | int:CNBP | |
| Interaction | ZNF397 interactions | 8.27e-04 | 62 | 14 | 2 | int:ZNF397 | |
| Interaction | GNAI2 interactions | 8.36e-04 | 277 | 14 | 3 | int:GNAI2 | |
| Interaction | ZNF331 interactions | 8.54e-04 | 63 | 14 | 2 | int:ZNF331 | |
| Interaction | PLAT interactions | 8.54e-04 | 63 | 14 | 2 | int:PLAT | |
| Interaction | SLIT2 interactions | 8.54e-04 | 63 | 14 | 2 | int:SLIT2 | |
| Interaction | FBN2 interactions | 9.09e-04 | 65 | 14 | 2 | int:FBN2 | |
| Interaction | HLA-A interactions | 9.45e-04 | 289 | 14 | 3 | int:HLA-A | |
| Interaction | SERPINH1 interactions | 1.11e-03 | 306 | 14 | 3 | int:SERPINH1 | |
| Interaction | RPL36AL interactions | 1.15e-03 | 309 | 14 | 3 | int:RPL36AL | |
| Interaction | YTHDF2 interactions | 1.18e-03 | 312 | 14 | 3 | int:YTHDF2 | |
| Interaction | HYOU1 interactions | 1.23e-03 | 317 | 14 | 3 | int:HYOU1 | |
| Interaction | KRT6C interactions | 1.24e-03 | 76 | 14 | 2 | int:KRT6C | |
| Interaction | EGFL7 interactions | 1.27e-03 | 77 | 14 | 2 | int:EGFL7 | |
| Interaction | ZNF707 interactions | 1.34e-03 | 79 | 14 | 2 | int:ZNF707 | |
| Interaction | GPC4 interactions | 1.34e-03 | 79 | 14 | 2 | int:GPC4 | |
| Interaction | EPC1 interactions | 1.41e-03 | 81 | 14 | 2 | int:EPC1 | |
| Interaction | ZNF592 interactions | 1.41e-03 | 81 | 14 | 2 | int:ZNF592 | |
| Interaction | UBR4 interactions | 1.43e-03 | 334 | 14 | 3 | int:UBR4 | |
| Interaction | ACTN1 interactions | 1.52e-03 | 341 | 14 | 3 | int:ACTN1 | |
| Interaction | CYBC1 interactions | 1.58e-03 | 86 | 14 | 2 | int:CYBC1 | |
| Interaction | MAZ interactions | 1.58e-03 | 86 | 14 | 2 | int:MAZ | |
| Interaction | SPTB interactions | 1.62e-03 | 87 | 14 | 2 | int:SPTB | |
| Interaction | RPN2 interactions | 1.65e-03 | 782 | 14 | 4 | int:RPN2 | |
| Interaction | DNAJB11 interactions | 1.65e-03 | 351 | 14 | 3 | int:DNAJB11 | |
| Interaction | TAF3 interactions | 1.66e-03 | 88 | 14 | 2 | int:TAF3 | |
| Interaction | TIMP3 interactions | 1.73e-03 | 90 | 14 | 2 | int:TIMP3 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr7q36 | 1.22e-03 | 159 | 15 | 2 | chr7q36 | |
| GeneFamily | Low density lipoprotein receptors | 2.14e-05 | 13 | 10 | 2 | 634 | |
| ToppCell | facs-Skin-Skin_Anagen-18m-Epithelial-basal_cell_of_epidermis|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.06e-07 | 190 | 15 | 4 | 3639eb9b887a2d76949cad4a2586524fe0e1015f | |
| ToppCell | facs-Skin-Skin_Anagen-18m-Epithelial-nan|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.32e-07 | 193 | 15 | 4 | bc7e0b6b07be91901f02f1524fb81f3c538ab6b9 | |
| ToppCell | facs-Skin-Skin_Anagen-18m-Epithelial|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.50e-07 | 195 | 15 | 4 | 2c03d1a2f208b6737311458a4bd8f2e4444de29a | |
| ToppCell | facs-Skin-Skin_Anagen|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.50e-07 | 195 | 15 | 4 | ffd87cc7ae9b141bf48e072ea1a1420794499790 | |
| ToppCell | facs-Skin-Skin_Anagen-18m|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.50e-07 | 195 | 15 | 4 | 0d37dd66a8d60fc9cda3d6e3c4fbe67e577b890e | |
| ToppCell | Control-Classical_Monocyte-cMono_3|Control / Disease condition and Cell class | 1.39e-05 | 143 | 15 | 3 | 9d1cee36e32aefb6af5c65b3281b31a45d5cd17e | |
| ToppCell | facs-Skin-Skin_Anagen-18m-Epithelial-epidermal_cell|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.46e-05 | 173 | 15 | 3 | 0f9c1d3298e59e6d22bb3306f0f445f490be8bbd | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-Mono-Mono_anti-infl-A|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.50e-05 | 174 | 15 | 3 | 062e7bd9072ca7ee68e09b1da28af13f1bc60b44 | |
| ToppCell | droplet-Lung-nan-3m-Mesenchymal-pericyte_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.63e-05 | 177 | 15 | 3 | 65709bd546cb1ec6aa2ddd8b2adb46e174eb9a9a | |
| ToppCell | droplet-Lung-nan-3m-Mesenchymal-Pericyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.63e-05 | 177 | 15 | 3 | 8684d47a547e2a06496f15e8da0200ecddc431e0 | |
| ToppCell | normal_Lymph_Node-Myeloid_cells-CD141+_DCs|normal_Lymph_Node / Location, Cell class and cell subclass | 2.72e-05 | 179 | 15 | 3 | ec995ccd6e1dbd06287ad836c232d9aed1cf94a8 | |
| ToppCell | 10x5'-lymph-node_spleen-Myeloid_Dendritic-DC1|lymph-node_spleen / Manually curated celltypes from each tissue | 2.91e-05 | 183 | 15 | 3 | c9e3d91f4c3395a73295b92e25608e0effb5d241 | |
| ToppCell | 3'_v3-GI_small-bowel-Myeloid_Dendritic-DC1|GI_small-bowel / Manually curated celltypes from each tissue | 2.95e-05 | 184 | 15 | 3 | 8e393eea7240584a3cef718bee094e2705ec1891 | |
| ToppCell | E18.5-samps-Mesenchymal|E18.5-samps / Age Group, Lineage, Cell class and subclass | 3.20e-05 | 189 | 15 | 3 | 0c18d3de4720759cf802eefb4d0ddde2a9246a1a | |
| ToppCell | P03-Mesenchymal-developing_mesenchymal_cell-mesenchymal_myogenic_precursor_(Axin2+)|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 3.25e-05 | 190 | 15 | 3 | 979b1476fd2692fde977ce56257315fcfc8a01d5 | |
| ToppCell | E16.5-samps-Mesenchymal-Matrix_fibroblast-_fetal|E16.5-samps / Age Group, Lineage, Cell class and subclass | 3.30e-05 | 191 | 15 | 3 | 3379d145d34f89150f7b06d1340022cfc6b4a6ce | |
| ToppCell | Control-Stromal_mesenchymal|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.30e-05 | 191 | 15 | 3 | 14057205ddb9b4bbc582d1358d13cf36d979a61b | |
| ToppCell | facs-Lung-3m-Mesenchymal-fibroblast-alveolar_fibroblast|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.30e-05 | 191 | 15 | 3 | beb5bb42bd53bce01339da9110d374901548793c | |
| ToppCell | facs-Lung-3m-Mesenchymal-fibroblast-alveolar_fibroblast-alveolar_fibroblast_l49|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.30e-05 | 191 | 15 | 3 | 6609d85fd2577633dcc067507304a6f9e5865ca3 | |
| ToppCell | facs-Lung-EPCAM-3m-Mesenchymal|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.40e-05 | 193 | 15 | 3 | abdfb8b1dbdcb424042e21017a9e829fced4457e | |
| ToppCell | facs-Lung-EPCAM-3m-Mesenchymal-fibroblast_of_lung|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.40e-05 | 193 | 15 | 3 | 027e098ad018e782287f84eee0f77551018f2196 | |
| ToppCell | facs-Lung-EPCAM-3m-Mesenchymal-Alveolar_Fibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.40e-05 | 193 | 15 | 3 | c5463a87f20b3a7f7ffda677b2f5a0e9e49d6685 | |
| ToppCell | PND01-03-samps-Mesenchymal|PND01-03-samps / Age Group, Lineage, Cell class and subclass | 3.46e-05 | 194 | 15 | 3 | 4f9bd0ded0dde1df885850714f29e73e992539a5 | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Hematopoietic-Myeloid-LYVE1+_Macrophage|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.51e-05 | 195 | 15 | 3 | 028622b234551b185977fbee10c06851a45456a5 | |
| ToppCell | (6)_Macrophage|World / shred on Cell_type and subtype | 3.62e-05 | 197 | 15 | 3 | 010b275d4da4a896175ad7fbaa96d1dc11a0b744 | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Hematopoietic-Myeloid|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.62e-05 | 197 | 15 | 3 | 67bf15ee83938bd40f6ecd5abaaf90ad95096d21 | |
| ToppCell | 10x_3'_v3-tissue-resident_(10x_3'_v3)|10x_3'_v3 / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 3.67e-05 | 198 | 15 | 3 | ff9c97c6f579a4e79859d420f224556fadc1f6ab | |
| ToppCell | (04)_Interm._basal>secr.|World / shred by cell type by condition | 3.73e-05 | 199 | 15 | 3 | ed399244433f781fc291a9bff16825b8a3ca294f | |
| ToppCell | Caecum-Dendritic_cell-cDC1|Caecum / Region, Cell class and subclass | 3.73e-05 | 199 | 15 | 3 | 9ab38a0060a883de6fe3da8cdac42e124d7981d9 | |
| ToppCell | Caecum-(5)_Dendritic_cell-(51)_cDC1|Caecum / shred on region, Cell_type, and subtype | 3.73e-05 | 199 | 15 | 3 | 2b97fda45241b2ce7be904cf081cabcf3eb5ba1d | |
| ToppCell | Transverse-Macrophage-Macrophage|Transverse / Region, Cell class and subclass | 3.79e-05 | 200 | 15 | 3 | 17548806ba38008050244151d1216c69ef8a8310 | |
| ToppCell | Transverse-(6)_Macrophage|Transverse / shred on region, Cell_type, and subtype | 3.79e-05 | 200 | 15 | 3 | b28350de555fa756d2631f004f71d5ac69b1affe | |
| ToppCell | mLN-(6)_Macrophage-(61)_LYVE1_Macrophage|mLN / shred on region, Cell_type, and subtype | 3.79e-05 | 200 | 15 | 3 | a20f5ec61d492d8a2adf695ec304b5d57296aa8f | |
| ToppCell | Transverse-(6)_Macrophage-(60)_Macrophage|Transverse / shred on region, Cell_type, and subtype | 3.79e-05 | 200 | 15 | 3 | 2be675684a2958ea609939bb45248bede78a26bc | |
| ToppCell | mLN-Macrophage-LYVE1_Macrophage|mLN / Region, Cell class and subclass | 3.79e-05 | 200 | 15 | 3 | 89cf739a3c2f5d30e547404f2f2ec6500cd1d65d | |
| ToppCell | Transverse-Macrophage|Transverse / Region, Cell class and subclass | 3.79e-05 | 200 | 15 | 3 | 1920605e5811938814d02b971069a4506868db5f | |
| ToppCell | (60)_Macrophage|World / shred on Cell_type and subtype | 4.01e-05 | 204 | 15 | 3 | 06d0cb306f1ad0014d81f8228868938e48c2bcf3 | |
| ToppCell | (61)_LYVE1_Macrophage|World / shred on Cell_type and subtype | 4.13e-05 | 206 | 15 | 3 | 711e961a9a03bfd2f0958bd14f25f7f207a2f2b5 | |
| ToppCell | Hippocampus-Endothelial-MURAL-M1(Rgs5Acta2)-M1_2-MURAL_Mural.Rgs5Acta2.Kcnj8_(Mural.Rgs5Acta2.Kcnj8)|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 4.18e-04 | 91 | 15 | 2 | 78e2e65beb15bf1e251974c72fbcfab817492772 | |
| ToppCell | Hippocampus-Endothelial-MURAL-M1(Rgs5Acta2)-M1_2-MURAL_Mural.Rgs5Acta2.Kcnj8_(Mural.Rgs5Acta2.Kcnj8)-|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 4.18e-04 | 91 | 15 | 2 | f59908093416ca7b3ca27019d71c79acbdea18cb | |
| ToppCell | Hippocampus-Endothelial-MURAL-M1(Rgs5Acta2)-M1_2|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 4.18e-04 | 91 | 15 | 2 | 104d2ab9fe5cc404388c32fafb34e421c2e138be | |
| ToppCell | LPS_only-Myeloid-Dendritic_cells-Monocytes-Macrophages|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.31e-04 | 112 | 15 | 2 | 9801227fe5a6f5ae1b6c5a9e7fa7f35c4c52efe1 | |
| ToppCell | BAL-Control-cDC_7|Control / Compartment, Disease Groups and Clusters | 7.36e-04 | 121 | 15 | 2 | b49b044a687a31883dfccecf10a183b5ba567f7a | |
| ToppCell | droplet-Fat-Mat-18m-Mesenchymal-nan|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.36e-04 | 121 | 15 | 2 | e82c9e10b98c8d7ad828cf8ac19a2342014be2ba | |
| ToppCell | frontal_cortex-Non-neuronal-leptomeningeal_cell-VLMC-VLMC_Spp1_Hs3st6|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 7.60e-04 | 123 | 15 | 2 | 64a2d7e40d9c948a9ccaf61c465fb2207e0b7ab8 | |
| ToppCell | PND01-03-samps-Lymphocyte-B_cell-B_cell_1|PND01-03-samps / Age Group, Lineage, Cell class and subclass | 8.23e-04 | 128 | 15 | 2 | 5d82247ceda55017628720ed8b6c36ff7cec8437 | |
| ToppCell | LPS-antiTNF-Myeloid-Dendritic_cells-Monocytes-Macrophages|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.23e-04 | 128 | 15 | 2 | cfc73cb803ba50a4a8709e19e70e1e399118c849 | |
| ToppCell | PND01-03-samps-Lymphocyte-B_cell|PND01-03-samps / Age Group, Lineage, Cell class and subclass | 8.23e-04 | 128 | 15 | 2 | 7661402dd7cd533c1bfe8d9247cecd88c1be9a5e | |
| ToppCell | PND01-03-samps-Lymphocyte|PND01-03-samps / Age Group, Lineage, Cell class and subclass | 8.23e-04 | 128 | 15 | 2 | d3158825a2178244b57ac5ad2676617fd58d8466 | |
| ToppCell | Smart-seq2-spleen_(Smart-seq2)-myeloid-myeloid_macrophage-macrophage|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 8.62e-04 | 131 | 15 | 2 | aaf87b85fa5886808407ea91721058aaad3472a6 | |
| ToppCell | Smart-seq2-spleen_(Smart-seq2)-myeloid-myeloid_macrophage|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 8.62e-04 | 131 | 15 | 2 | 384952292627316db18b522066a29ebbc3a6723b | |
| ToppCell | LPS-IL1RA+antiTNF-Myeloid-Dendritic_cells-mDC|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.75e-04 | 132 | 15 | 2 | f8e2ba53063007d7507f1837ad669b0e4333cd23 | |
| ToppCell | RV-14._Fibroblast_III|World / Chamber and Cluster_Paper | 9.01e-04 | 134 | 15 | 2 | 8c4046ba1f85172915a112499e492c3efe8474c2 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-24m-Macroglial|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.55e-04 | 138 | 15 | 2 | c1a46fbf1beffa12c3d1b78361e0613e2e9e2d13 | |
| ToppCell | primary_visual_cortex-Non-neuronal-leptomeningeal_cell-VLMC-VLMC_Spp1_Col15a1|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.01e-03 | 142 | 15 | 2 | f4e4cde228149d5a536fbf0517ed71d81e296faf | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Myeloid-Dendritic-plasmacytoid_dendritic_cell-DC_c4-LILRA4|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.03e-03 | 143 | 15 | 2 | d0ed8c25da1327085e042c2e03cb7503e2c52ce0 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Myeloid-Dendritic-plasmacytoid_dendritic_cell|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.03e-03 | 143 | 15 | 2 | 8900b92a24289204b9ec7baccc11594fec7694f1 | |
| ToppCell | LPS-IL1RA+antiTNF-Myeloid-Dendritic_cells-Monocytes-Macrophages|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.07e-03 | 146 | 15 | 2 | b76110b159acd27a2c8d6a9f98336608ace1ec12 | |
| ToppCell | Control-Classical_Monocyte-cMono_3|Classical_Monocyte / Disease condition and Cell class | 1.07e-03 | 146 | 15 | 2 | fcd8548b42275758d7d77ad2651afe7ad0e5ea2a | |
| ToppCell | E16.5-samps-Myeloid-Macrophage-CD163+_Macrophage|E16.5-samps / Age Group, Lineage, Cell class and subclass | 1.10e-03 | 148 | 15 | 2 | 56e146980a71b5ca655118ae13310c5949220d4a | |
| ToppCell | E16.5-samps-Myeloid-Macrophage|E16.5-samps / Age Group, Lineage, Cell class and subclass | 1.10e-03 | 148 | 15 | 2 | cd5f697d8c2f272be1f3f52a05446749278431c5 | |
| ToppCell | E16.5-samps-Mesenchymal-Matrix_fibroblast-_fetal-matrix_-_immature_3|E16.5-samps / Age Group, Lineage, Cell class and subclass | 1.11e-03 | 149 | 15 | 2 | 651494e84be03dc7b061ebdfa91756a1c507b9b4 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-24m-Macroglial-oligodendrocyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.13e-03 | 150 | 15 | 2 | afd651c654e715414eff64cf3a37378d057a56a2 | |
| ToppCell | 390C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_0.5|CD8+_Cytotoxic_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 1.17e-03 | 153 | 15 | 2 | e7d20c88466ff81db613869cf7a6a4bb95fd6c2f | |
| ToppCell | 368C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_6|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 1.19e-03 | 154 | 15 | 2 | ba55a63cfa5e0fb9dfec794f80078a2f0d03d0ad | |
| ToppCell | Basal_cells-Donor_05|World / lung cells shred on cell class, cell subclass, sample id | 1.20e-03 | 155 | 15 | 2 | 30accc72a6a914ae0c4d52b373ea1c9a98efbf22 | |
| ToppCell | 10x5'-Liver-Myeloid_Mac-Intestinal_macrophages|Liver / Manually curated celltypes from each tissue | 1.22e-03 | 156 | 15 | 2 | 9a897fc79c4fae94c5f2e9012d65297f9225e5e3 | |
| ToppCell | PND03-Immune-Immune_Myeloid-Monocytic-Macrophage-iMON-iMON_prolif|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.23e-03 | 157 | 15 | 2 | eea53cf8d8a607264e1ee00b7a97c94bcf2ac80d | |
| ToppCell | wk_15-18-Mesenchymal-Myofibro_&_SMC-Myofibro_2|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 1.23e-03 | 157 | 15 | 2 | b9d04ee417c0d8ea0801d10f1c54e138587009fd | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Myeloid-Dendritic-conventional_dendritic_cell-DC_c1-CLEC9A|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.23e-03 | 157 | 15 | 2 | 19c0599a669803c4db1f174de1ce755e562a50a3 | |
| ToppCell | 368C-Myeloid-Dendritic-cDC1|368C / Donor, Lineage, Cell class and subclass (all cells) | 1.25e-03 | 158 | 15 | 2 | c276a259e20ee704e2d04baf693e8d677f96f654 | |
| ToppCell | E18.5-samps-Mesenchymal-Matrix_fibroblast-FB-1|E18.5-samps / Age Group, Lineage, Cell class and subclass | 1.26e-03 | 159 | 15 | 2 | b4bc888e978b1b577721b891b0af6ba9a1607044 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Myeloid-Granulocytic-Neutrophil-Neu_c1-IL1B|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.26e-03 | 159 | 15 | 2 | fb9a45c1d596226128ce4f1adaebb066766e590a | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.28e-03 | 160 | 15 | 2 | c381ec6be8cf887861cc18f831a20db42f953fe1 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-Mono-Mono_hypoxia-B|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.28e-03 | 160 | 15 | 2 | 6ed37d1fd0304932319d6b942502404115ff36a7 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.28e-03 | 160 | 15 | 2 | 25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585 | |
| ToppCell | 10x5'-bone_marrow-Myeloid_Dendritic-DC1|bone_marrow / Manually curated celltypes from each tissue | 1.30e-03 | 161 | 15 | 2 | 2f068ee643de2f647c289779a6624265ab9a749b | |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma-Astrocytoma|TCGA-Brain / Sample_Type by Project: Shred V9 | 1.31e-03 | 162 | 15 | 2 | 810881210e015c788814e4fe8d7a24c929cf2621 | |
| ToppCell | Control-B_intermediate-10|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 1.31e-03 | 162 | 15 | 2 | aa80452b972bb8ad3670ffaba4ce26fadb33b185 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-vascular_smooth_muscle_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.33e-03 | 163 | 15 | 2 | 8f24cef152f5965727bbeee116bd26c75cbba82a | |
| ToppCell | PND10-Epithelial-Epithelial_Airway-Neurosecretory-Secretory-Secretory_prolif|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.34e-03 | 164 | 15 | 2 | 6ea188e17895961cd112152fb111d08641cc5e45 | |
| ToppCell | droplet-Pancreas-Exocrine-24m-Epithelial-pancreatic_acinar_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.36e-03 | 165 | 15 | 2 | 622aca1d49bd8c917b131e4f4959d9dba411d22b | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-Mono-Mono_hypoxia-A|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.38e-03 | 166 | 15 | 2 | ce570b768988e30898cf0387c2aa99989631f13f | |
| ToppCell | 367C-Myeloid-Monocyte-CD16+_Monocyte|367C / Donor, Lineage, Cell class and subclass (all cells) | 1.38e-03 | 166 | 15 | 2 | 430d604f5bef9fae20dc81492e6695616f6701a3 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-Mono-Mono_naive-A|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.39e-03 | 167 | 15 | 2 | 1cd9e2af85c6c5b9e1d88991c87ac6980b387243 | |
| ToppCell | droplet-Lung-LUNG-1m-Myeloid-dendritic_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.39e-03 | 167 | 15 | 2 | e30e7ac8ea4399dc3c1d94fc6b857afc80a7a671 | |
| ToppCell | 343B-Lymphocytic-CD4_T-cell-Proliferating_T_cell|343B / Donor, Lineage, Cell class and subclass (all cells) | 1.39e-03 | 167 | 15 | 2 | 315cde87eed2b42a1b9b068fae94caa10ec64c70 | |
| ToppCell | droplet-Pancreas-Exocrine-24m-Epithelial-pancreatic_acinar_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.39e-03 | 167 | 15 | 2 | 3c06894fc6177f3c204094719904da42f08b9af8 | |
| ToppCell | LPS-antiTNF-Myeloid-Dendritic_cells-mDC|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.41e-03 | 168 | 15 | 2 | 2dca1c4a33b6da9357fa3b2a523af19baab1c21c | |
| ToppCell | frontal_cortex-Non-neuronal-leptomeningeal_cell-VLMC-VLMC_Osr1_Mc5r|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.41e-03 | 168 | 15 | 2 | 9930bd63b60c03f0152838a79eef77da1c2dd8e5 | |
| ToppCell | droplet-Pancreas-Exocrine-24m-Epithelial|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.41e-03 | 168 | 15 | 2 | 100ab6d36592b61f4db9f8cb90c48afac016d679 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Myeloid-Dendritic|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.43e-03 | 169 | 15 | 2 | a0681317867e31319210a23e56660a53f4529efe | |
| ToppCell | facs-Marrow-KLS-3m-Hematologic-Unknown_Progenitor|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.43e-03 | 169 | 15 | 2 | b798b91567d2f49082e2d8a337169f241c8d2080 | |
| ToppCell | droplet-Thymus-nan-18m-Myeloid-Macrophage|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.43e-03 | 169 | 15 | 2 | 4ac21e8199de4b6917eacadc56fffc6d886ee643 | |
| ToppCell | myeloid-Monocyte-CD14+_Monocyte|Monocyte / Lineage, cell class and subclass | 1.43e-03 | 169 | 15 | 2 | 7c3144a6599787f28662f5b22b8e45f4a115aeda | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c04-ANXA2|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.43e-03 | 169 | 15 | 2 | 01a24a8817628125bd004b2be68ffa62c7111f6e | |
| ToppCell | normal_Pleural_Fluid-Myeloid_cells-Monocytes|normal_Pleural_Fluid / Location, Cell class and cell subclass | 1.43e-03 | 169 | 15 | 2 | 7b71463f0fd802b422c8d394a435901009ca200f | |
| ToppCell | wk_08-11-Mesenchymal-Myofibro_&_SMC-Myofibro_2|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 1.44e-03 | 170 | 15 | 2 | fefb07a7e308b620f946b9ff2b01e1796446fe38 | |
| ToppCell | 390C-Myeloid-Macrophage-SPP1+_Macrophage_4|390C / Donor, Lineage, Cell class and subclass (all cells) | 1.44e-03 | 170 | 15 | 2 | 439167e44a1bd5ac8e1e457351dd202ec968db46 | |
| ToppCell | LPS-antiTNF-Myeloid-Dendritic_cells|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.44e-03 | 170 | 15 | 2 | 3cbeea6bfa500928c413b1c6129f6dedc769cd1e | |
| Drug | Orphenadrine hydrochloride [341-69-5]; Down 200; 13uM; PC3; HT_HG-U133A | 6.89e-06 | 197 | 15 | 4 | 3801_DN | |
| Drug | Citalopram hydrobromide [59729-32-7]; Up 200; 1uM; PC3; HT_HG-U133A | 6.89e-06 | 197 | 15 | 4 | 4555_UP | |
| Drug | K0-24 | 1.13e-05 | 8 | 15 | 2 | CID000066137 | |
| Drug | dihydrolipoamide | 6.05e-05 | 119 | 15 | 3 | CID000000663 | |
| Drug | simvastatin | 9.96e-05 | 390 | 15 | 4 | CID000054454 | |
| Drug | ezetimibe | 1.13e-04 | 147 | 15 | 3 | CID000150311 | |
| Drug | 25-hydroxycholesterol | 1.46e-04 | 160 | 15 | 3 | CID000065094 | |
| Drug | AC1L3UFA | 1.52e-04 | 28 | 15 | 2 | CID000122350 | |
| Drug | monatepil | 1.63e-04 | 29 | 15 | 2 | CID000060810 | |
| Drug | guanidinoethylmercaptosuccinic acid | 2.38e-04 | 35 | 15 | 2 | CID000003464 | |
| Drug | Nadolol [42200-33-9]; Up 200; 13uM; PC3; HT_HG-U133A | 2.57e-04 | 194 | 15 | 3 | 4021_UP | |
| Drug | Tadjakonine [11087-94-8]; Up 200; 7.4uM; PC3; HT_HG-U133A | 2.57e-04 | 194 | 15 | 3 | 4599_UP | |
| Drug | Delcorine; Down 200; 8.4uM; PC3; HT_HG-U133A | 2.57e-04 | 194 | 15 | 3 | 4275_DN | |
| Drug | Ivermectin [70288-86-7]; Down 200; 4.6uM; MCF7; HT_HG-U133A | 2.57e-04 | 194 | 15 | 3 | 2213_DN | |
| Drug | Etifenin [63245-28-3]; Up 200; 12.4uM; MCF7; HT_HG-U133A | 2.57e-04 | 194 | 15 | 3 | 4117_UP | |
| Drug | Clofilium tosylate [92953-10-1]; Down 200; 7.8uM; PC3; HT_HG-U133A | 2.57e-04 | 194 | 15 | 3 | 4492_DN | |
| Drug | Chicago sky blue 6B [2610-05-1]; Up 200; 4uM; MCF7; HT_HG-U133A | 2.61e-04 | 195 | 15 | 3 | 4971_UP | |
| Drug | Testosterone propionate [57-85-2]; Up 200; 11.6uM; MCF7; HT_HG-U133A | 2.61e-04 | 195 | 15 | 3 | 5636_UP | |
| Drug | Kawain [500-64-1]; Down 200; 17.4uM; PC3; HT_HG-U133A | 2.61e-04 | 195 | 15 | 3 | 3670_DN | |
| Drug | (-) -Levobunolol hydrochloride [27912-14-7]; Up 200; 12.2uM; PC3; HT_HG-U133A | 2.61e-04 | 195 | 15 | 3 | 4016_UP | |
| Drug | Cephalexin monohydrate [23325-78-2]; Down 200; 11uM; MCF7; HT_HG-U133A | 2.65e-04 | 196 | 15 | 3 | 5615_DN | |
| Drug | Amiprilose hydrochloride [60414-06-4]; Up 200; 11.8uM; MCF7; HT_HG-U133A | 2.65e-04 | 196 | 15 | 3 | 4119_UP | |
| Drug | Methyldopate hydrochloride [2508-79-4]; Down 200; 14.6uM; MCF7; HT_HG-U133A | 2.65e-04 | 196 | 15 | 3 | 7360_DN | |
| Drug | Bezafibrate [41859-67-0]; Up 200; 11uM; MCF7; HT_HG-U133A | 2.69e-04 | 197 | 15 | 3 | 2630_UP | |
| Drug | Carteolol hydrochloride [51781-21-6]; Down 200; 12.2uM; PC3; HT_HG-U133A | 2.69e-04 | 197 | 15 | 3 | 4096_DN | |
| Drug | valdecoxib; Down 200; 10uM; PC3; HT_HG-U133A | 2.69e-04 | 197 | 15 | 3 | 6408_DN | |
| Drug | Apramycin [37321-09-8]; Up 200; 7.4uM; MCF7; HT_HG-U133A | 2.69e-04 | 197 | 15 | 3 | 4959_UP | |
| Drug | Rifampicin [13292-46-1]; Up 200; 4.8uM; MCF7; HT_HG-U133A | 2.73e-04 | 198 | 15 | 3 | 4126_UP | |
| Drug | Ifosfamide [3778-73-2]; Up 200; 15.4uM; PC3; HT_HG-U133A | 2.73e-04 | 198 | 15 | 3 | 5805_UP | |
| Drug | Pralidoxime chloride [51-15-0]; Down 200; 23.2uM; MCF7; HT_HG-U133A | 2.73e-04 | 198 | 15 | 3 | 5383_DN | |
| Drug | Riluzole hydrochloride; Down 200; 14.8uM; PC3; HT_HG-U133A | 2.73e-04 | 198 | 15 | 3 | 3666_DN | |
| Drug | Chlorpropamide [94-20-2]; Down 200; 14.4uM; MCF7; HT_HG-U133A | 2.73e-04 | 198 | 15 | 3 | 5391_DN | |
| Drug | CP-690334-01 [459212-38-5]; Down 200; 1uM; MCF7; HT_HG-U133A | 2.77e-04 | 199 | 15 | 3 | 4383_DN | |
| Drug | Scopolamin-N-oxide hydrobromide [6106-81-6]; Up 200; 10uM; MCF7; HT_HG-U133A | 2.77e-04 | 199 | 15 | 3 | 5436_UP | |
| Drug | Pyrazinamide [ 98-96-4]; Up 200; 32.4uM; MCF7; HT_HG-U133A | 2.77e-04 | 199 | 15 | 3 | 4962_UP | |
| Drug | Perphenazine [58-39-9]; Down 200; 10uM; MCF7; HT_HG-U133A | 2.77e-04 | 199 | 15 | 3 | 5698_DN | |
| Drug | Nimodipine [66085-59-4]; Down 200; 9.6uM; MCF7; HT_HG-U133A | 2.77e-04 | 199 | 15 | 3 | 5421_DN | |
| Drug | Pirenzepine dihydrochloride [29868-97-1]; Up 200; 9.4uM; PC3; HT_HG-U133A | 2.77e-04 | 199 | 15 | 3 | 5872_UP | |
| Drug | Clenbuterol hydrochloride [21898-19-1]; Up 200; 12.8uM; MCF7; HT_HG-U133A | 2.77e-04 | 199 | 15 | 3 | 3228_UP | |
| Drug | Dihydroergotoxine mesylate [8067-24-1]; Down 200; 6.4uM; PC3; HT_HG-U133A | 2.77e-04 | 199 | 15 | 3 | 4071_DN | |
| Drug | PHA-00851261E [724719-49-7]; Up 200; 10uM; PC3; HT_HG-U133A | 2.77e-04 | 199 | 15 | 3 | 4330_UP | |
| Drug | GPGR | 2.81e-04 | 38 | 15 | 2 | CID000485268 | |
| Drug | Florfenicol [73231-34-2]; Up 200; 11.2uM; PC3; HT_HG-U133A | 2.81e-04 | 200 | 15 | 3 | 6701_UP | |
| Drug | AC1L9KZ2 | 4.49e-04 | 48 | 15 | 2 | CID000447561 | |
| Disease | Solid Neoplasm | 5.06e-06 | 7 | 15 | 2 | C0280100 | |
| Disease | Lymphoma | 1.86e-04 | 40 | 15 | 2 | C0024299 | |
| Disease | Diffuse Large B-Cell Lymphoma | 3.53e-04 | 55 | 15 | 2 | C0079744 | |
| Disease | stomach cancer (is_implicated_in) | 6.04e-04 | 72 | 15 | 2 | DOID:10534 (is_implicated_in) | |
| Disease | lung cancer (is_implicated_in) | 6.38e-04 | 74 | 15 | 2 | DOID:1324 (is_implicated_in) | |
| Disease | Polydactyly | 1.58e-03 | 117 | 15 | 2 | C0152427 | |
| Disease | colorectal cancer (is_implicated_in) | 1.69e-03 | 121 | 15 | 2 | DOID:9256 (is_implicated_in) | |
| Disease | Papillary Renal Cell Carcinoma | 1.89e-03 | 128 | 15 | 2 | C1306837 | |
| Disease | Renal Cell Carcinoma | 1.89e-03 | 128 | 15 | 2 | C0007134 | |
| Disease | Sarcomatoid Renal Cell Carcinoma | 1.89e-03 | 128 | 15 | 2 | C1266043 | |
| Disease | Chromophobe Renal Cell Carcinoma | 1.89e-03 | 128 | 15 | 2 | C1266042 | |
| Disease | Collecting Duct Carcinoma of the Kidney | 1.89e-03 | 128 | 15 | 2 | C1266044 | |
| Disease | Takayasu arteritis | 2.51e-03 | 148 | 15 | 2 | EFO_1001857 | |
| Disease | Conventional (Clear Cell) Renal Cell Carcinoma | 2.51e-03 | 148 | 15 | 2 | C0279702 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| GNAHCADCGAADPDW | 21 | Q9NPF8 | |
| EACNSHACQWDGGDC | 1441 | Q04721 | |
| HTGERPFACDWQGCD | 151 | Q9BXK1 | |
| GRCIPGHWACDGDND | 1016 | Q9NZR2 | |
| GHWACDGDNDCGDFS | 1021 | Q9NZR2 | |
| DPDLCLTCGAADHWD | 581 | Q15910 | |
| PGFCDECQDWTWGEH | 1176 | Q7Z7M0 | |
| FWAGNCSEAACGAAD | 1986 | Q7Z7M0 | |
| WASGNGGREHDSCNC | 291 | P09958 | |
| GAWDCSVENGGCEHA | 241 | P07204 | |
| VPHGWLCDNQDDCGD | 1391 | A2VEC9 | |
| LHECPGTAGADDCWQ | 441 | Q2M3G4 | |
| DFGDWSDHCPKGACG | 161 | Q7Z5L0 | |
| CEADGQWSSGFPHCE | 3046 | Q4LDE5 | |
| NWCDGVSHCPGGEDE | 131 | O15393 | |
| CDAFGSWEPVQCHAG | 1031 | P01266 | |
| PAQWQCDGDNDCGDH | 46 | O75096 | |
| LWHCDGDNDCGDNSD | 126 | O75096 |